博浩達(dá)生物是一家專注于全球生物技術(shù)研究與投資、工業(yè)生物研發(fā)、生產(chǎn)和銷售的全球化高科技公司，由中國(guó)科學(xué)院天津工業(yè)生物技術(shù)研究所和遠(yuǎn)泓生物發(fā)起成立，注冊(cè)資本1億元，占地118.59畝?，F(xiàn)有員工120多人，其中研發(fā)技術(shù)人員占比超過30%。 公司堅(jiān)持采用國(guó)際標(biāo)準(zhǔn)確保提高產(chǎn)品質(zhì)量，建立了完善的質(zhì)量檢測(cè)控制體系及國(guó)內(nèi)領(lǐng)先的全自動(dòng)化智能生產(chǎn)基地。憑借獨(dú)特的技術(shù)優(yōu)勢(shì)，已成功與美國(guó)、德國(guó)、法國(guó)、英國(guó)、日本、意大利、荷蘭、泰國(guó)、印度、越南、巴西、韓國(guó)等國(guó)飼料、食品、醫(yī)藥企業(yè)建立銷售合作伙伴關(guān)系。未來將通過產(chǎn)業(yè)鏈的擴(kuò)展與延伸，進(jìn)一步穩(wěn)固市場(chǎng)占有率、拓展市場(chǎng)價(jià)值，推動(dòng)綠色生物產(chǎn)業(yè)集群的形成和發(fā)展。

Bohaoda biotechnology is a high-tech company focusing on global biotechnology research and investment, industrial biological application research and development, production and sales of inositol. Bohaoda was founded in December 2018 with a registered capital of 100 million RMB and an area of 79060㎡. There are more than 90 employees, of which R&D and technical personnel account for more than 30%. With the core orientation of market and leading technology, we cooperate with Biotechnology R & D institutions in the United States, Germany, Canada, Israel, France and other countries abroad; At home, we cooperate with Tianjin Institute of industrial biotechnology, Chinese Academy of Sciences, Zhejiang University, Sichuan University and other units to build a platform for industrial biotechnology application R & D and pilot innovation.

At present, our core products have applied for 7 invention patents in China, the United States, Europe, Japan, South Korea, Thailand and Vietnam, and have already been authorized by China, the European union and South Korea. The company has applied for 5 new invention patents around the downstream application of core products. In response to the government's instructions, Bohaoda has established the world's first environmentally friendly intelligent production line of inositol. We adhere to the use of advanced equipment and detection and control means to achieve the best quality of similar products. It has initially established cooperation intentions with most food and pharmaceutical enterprises in the United States, Germany, France, Britain, Japan, Italy, the Netherlands, Thailand, India, Vietnam, Brazil, South Korea and other countries.